A 40-year-old woman presents with a very itchy bilateral rash on her ankles and feet, present for a few months. She has a few ...

Scientists turn dental floss into a vaccine tool that protected mice from lethal flu and triggered widespread immune response ...

ACROBiosystems is breaking the chain of chronic suffering and safeguarding intestinal health. Learn how in this article.

After Abivax announced the Phase III UC success, the company’s stock price on the Nasdaq exchange soared by 586%, from a $10.00 close on 22 July to a $68.60 close on 23 July. Ab ...

Montreal’s public health department is reporting a fresh uptick in mpox (clade 2b) cases, with six new infections recorded in ...

Willebrand disease (VWD) is considered the most common inherited bleeding disorder, even surpassing haemophilia A. Nevertheless, ...

A discovery at Hudson Institute more than 20 years ago is still sparking new medical insights, with researchers at a major US ...

Results from the Phase III ABTECT-1 (NCT05507203) and ABTECT-2 (NCT05507216) trials showed that Abivax’s obefazimod demonstrated significant clinical remission in patients with ulcerative colitis.